tirzepatide and nad+ Tirzepatide: The Metabolism Stack No One's Talking About (But Should Be) Fitish®️ | this is what

Peak appetite suppression often coincides with reaching the maintenance dose, usually between weeks 16-20 of treatment for those following the standard titration schedule

In high amounts, it's pro-oxidative

The factors of visceral neuropathy, acute dysglycemia, dysbiosis, and intestinal bacterial overgrowth contribute to the gastrointestinal symptoms in patients with diabetes, making it necessary to consider multiple etiologic factors in the presence of gastrointestinal symptoms, and not exclusively attribute them to the use of antidiabetics

The maintenance conversation happens at our practice constantly usually after a patient has reached goal weight and wants to know whether they really need the medication anymore

How & when to use